Stay updated on Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial

Sign up to get notified when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T14:25:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-24T14:05:02.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site footer revision updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T14:51:24.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T14:55:10.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry for v3.7.0 was added to the study record history on 2026-09-15 (version 29) indicating a Study Status update, while an older revision entry for v3.6.6 was removed on 2025-09-11.
    Difference
    0.4%
    Check dated 2026-09-19T22:19:57.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The record history adds a new Revision: v3.6.6 entry and removes the previous Revision: v3.6.5 entry.
    Difference
    0.1%
    Check dated 2026-08-29T20:14:31.000Z thumbnail image

Stay in the know with updates to Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.